Author

Bram L. T. Ramaekers

Observed names: B Ramaekers, B. L. Ramaekers, B. L. T. Ramaekers, B. Ramaekers, B.L.T. Ramaekers, BL Ramaekers, Bram L Ramaekers, Bram L T Ramaekers, Bram L. Ramaekers, Bram L.T. Ramaekers, Bram LT Ramaekers, Bram Ramaekers, L. T. Ramaekers, B., Ramaekers, B, Ramaekers, B., Ramaekers, B. L. T., Ramaekers, B. R., Ramaekers, Bram, Ramaekers, Bram L. T.

Institutions: Maastricht University Medical Centre, Maastricht University, Care and Public Health Research Institute

Observed institutions: Heidelberg University, Maastricht University Medical Centre, Institut Gustave Roussy, Maastricht University, Maastro Clinic, Care and Public Health Research Institute, National Cancer Center Hospital

ORCID: 0000-0001-5785-9228

Observed ORCID: 0000-0001-5785-9228

OpenAlex ID: A5065740152

Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis

2018 · Marie Westwood, Bram Ramaekers, et al. · Health Technology Assessment · 162

High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis

2015 · Marie Westwood, Thea van Asselt, et al. · Health Technology Assessment · 161

Decision support systems for personalized and participative radiation oncology

2016 · Philippe Lambin, Jaap Zindler, et al. · Advanced Drug Delivery Reviews · 154

Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis

2015 · Marie Westwood, Bram Ramaekers, et al. · Health Technology Assessment · 138

The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy

2011 · Bram L.T. Ramaekers, Manuela A. Joore, et al. · Oral Oncology · 131

Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis

2014 · Marie Westwood, Manuela Joore, et al. · Health Technology Assessment · 122

Systematic review and meta-analysis of radiotherapy in various head and neck cancers: Comparing photons, carbon-ions and protons

2010 · Bram L.T. Ramaekers, Madelon Pijls-Johannesma, et al. · Cancer Treatment Reviews · 101

A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis

2014 · Mickaël Hiligsmann, Silvia M. Evers, et al. · PharmacoEconomics · 100

Protons in Head-and-Neck Cancer: Bridging the Gap of Evidence

2012 · Bram L.T. Ramaekers, Janneke P.C. Grutters, et al. · International Journal of Radiation Oncology*Biology*Physics · 95

KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis

2014 · Marie Westwood, Thea van Asselt, et al. · Health Technology Assessment · 85

High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation

2021 · Marie Westwood, Bram Ramaekers, et al. · Health Technology Assessment · 77

Development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer – Comparison of dose, toxicity and cost-effectiveness

2016 · Qing Cheng, Erik Roelofs, et al. · Radiotherapy and Oncology · 76

Acknowledging Patient Heterogeneity in Economic Evaluation

2013 · Janneke P. C. Grutters, Mark Sculpher, et al. · PharmacoEconomics · 70

Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer

2009 · Philippe Lambin, Bram LT Ramaekers, et al. · Cochrane Database of Systematic Reviews · 68

Spacers in radiotherapy treatment of prostate cancer: Is reduction of toxicity cost-effective?

2015 · Ben G.L. Vanneste, Madelon Pijls-Johannesma, et al. · Radiotherapy and Oncology · 63

Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in Glioblastoma

2021 · Maikel Verduin, Sergey Primakov, et al. · Cancers · 52

ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis

2016 · Marie Westwood, Bram Ramaekers, et al. · Health Technology Assessment · 48

How Should We Deal with Patient Heterogeneity in Economic Evaluation: A Systematic Review of National Pharmacoeconomic Guidelines

2013 · Bram L.T. Ramaekers, Manuela A. Joore, et al. · Value in Health · 47

Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models

2019 · Sabine E. Grimm, Xavier Pouwels, et al. · PharmacoEconomics · 45

Adherence Among Telemonitored Patients with Heart Failure to Pharmacological and Nonpharmacological Recommendations

2009 · Bram L.T. Ramaekers, Josianne J. Janssen-Boyne, et al. · Telemedicine Journal and e-Health · 42

Optimizing the Use of High-Sensitivity Troponin Assays for the Early Rule-out of Myocardial Infarction in Patients Presenting with Chest Pain: A Systematic Review

2020 · Marie E Westwood, Nigel Armstrong, et al. · Clinical Chemistry · 35

Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer

2021 · Martijn J. H. G. Simons, Valesca P. Retèl, et al. · PharmacoEconomics · 33

Development of a virtual spacer to support the decision for the placement of an implantable rectum spacer for prostate cancer radiotherapy: Comparison of dose, toxicity and cost-effectiveness

2017 · Yvonka van Wijk, Ben G.L. Vanneste, et al. · Radiotherapy and Oncology · 31

Discrete-choice experiments versus rating scale exercises to evaluate the importance of attributes

2015 · Ben FM Wijnen, Inge M van der Putten, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 29

Sample Size Estimation for Non-Inferiority Trials: Frequentist Approach versus Decision Theory Approach

2015 · A. C. Bouman, A. J. ten Cate-Hoek, et al. · PLoS ONE · 28

Works count: 211

Citation count: 2,810

H-index: 26

I10-index: 62